A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients
Recruiting
Observational Study
Breast Neoplasms
Quality of Life (QOL)
Toxicities
Breast Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- FangYi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study, called PERSEVERE, examines how local treatment for early breast cancer affects people's health and daily lives over time.
People who join the study will have early-stage breast cancer and receive treatment such as surgery and other therapies that are used before or after surgery. The study does not include people with late-stage (metastatic) breast cancer.
Researchers want to learn a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women aged 18 years or older
* Diagnosed with stage I, II, or III invasive breast cancer confirmed by pathology or cytology
* No signs of metastatic disease (cancer that has spread to other parts of the body)
* Scheduled to receive local treatment, including:
Surgery
And/or …
Contacts